Topical Nepafenac Inhibits Ocular Neovascularization-Reference-Cited by-同舟云学术

Topical Nepafenac Inhibits Ocular Neovascularization

Published:2003-01-01 Issue:1 Volume:44 Page:409
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Takahashi Kyoichi¹,Saishin Yoshitsugu¹,Saishin Yumiko¹,Mori Keisuke¹,Ando Akira¹,Yamamoto Satoru¹,Oshima Yuji¹,Nambu Hiroyuki¹,Melia Michele B.¹,Bingaman David P.²,Campochiaro Peter A.¹

Affiliation:

1. From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and

2. Alcon Pharmaceutical Products Research, Alcon Research, Ltd., Fort Worth, Texas.

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes of Topical Bromfenac Combined with Intravitreal Aflibercept Injection for Exudative Age-related Macular Degeneration;Journal of the Korean Ophthalmological Society;2024-01-15

2. Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide as a Potential New Multitarget Therapeutic Candidate;Biomedicines;2023-05-27

3. Topical Nanoemulsion of a Runt-related Transcription Factor 1 Inhibitor for the Treatment of Pathologic Ocular Angiogenesis;Ophthalmology Science;2022-09

4. Etanercept as a TNF-alpha inhibitor depresses experimental retinal neovascularization;Graefe's Archive for Clinical and Experimental Ophthalmology;2020-10-12

5. An eye on the dog as the scientist's best friend for translational research in ophthalmology: Focus on the ocular surface;Medicinal Research Reviews;2020-07-31